首页> 外国专利> Compounds derived from piperazin - 1 - ilpidazina, Pharmaceutical Composition and use for treating a disease or condition mediated by Stearoyl COA desaturase (SCD) selected among Type II diabetes,Glucose intolerance, insulin resistance, hepatic steatosis, obesity, acne, dispipidemia and metabolic syndrome.

Compounds derived from piperazin - 1 - ilpidazina, Pharmaceutical Composition and use for treating a disease or condition mediated by Stearoyl COA desaturase (SCD) selected among Type II diabetes,Glucose intolerance, insulin resistance, hepatic steatosis, obesity, acne, dispipidemia and metabolic syndrome.

机译:衍生自哌嗪-1-哌啶嗪的化合物,药物组合物和用于治疗由硬脂酰COA去饱和酶(SCD)介导的疾病或病症的患者,选自II型糖尿病,葡萄糖耐量,胰岛素抵抗,肝脂肪变性,肥胖,痤疮,狼疮症和代谢综合征。

摘要

Methods of treating a disease or condition mediated by DCS in a Mammal, preferably a human being,Comprising administering to a Mammal in need of a compound of formula I, where X, y, W, V, R2, R3, R4, R5, R6, R7, R8, R9 r8a R7a,,, r9a, defined in the present.Pharmaceutical compositions comprising the compounds of formula (i).
机译:在哺乳动物中,优选在人类中,治疗由DCS介导的疾病或病症的方法,包括对需要式I的化合物的哺乳动物给药,其中X,y,W,V,R2,R3,R4,R5,在本发明中定义的R6,R7,R8,R9,R8a,R9a,R9a。药物组合物,其包含式(i)的化合物。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号